Cytological changes induced by intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

Urologia Internationalis

Volumn 64, Issue 2, 2000, Pages 74-81

  Takashi, Munehisa ^a,b   Schenck, Ulrich ^a   Koshikawa, Takashi ^b   Nakashima, Nobuo ^b   Ohshima, Shinichi ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacillus Calmette Guerin; Instillation therapy; Superficial bladder cancer; Urinary cytology

Indexed keywords

BCG VACCINE; EPIRUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CELL NUCLEUS; CELL VACUOLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOLUS; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; URINE CYTOLOGY; UROTHELIUM;

EID: 0034015108     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030495     Document Type: Article

References (30)

1. Soloway MS: Overview of treatment of superficial bladder cancer. Urology 1985;26 (suppl): 18-26.
2. Heney NM, Nocks BN, Daly JJ, Prout GR Jr, Newall JB, Griffin PP, Perrone TL, Szyfelbein WA: Ta and T1 bladder cancer: Location, recurrence and progression. Br J Urol 1982;54: 152-157.
3. Whelan P, Cumming JA, Garvie WHH, Hargreave TB, Kirk D, Newling DWW, Robinson MRG, Smith PH: Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Br J Urol 1991;67:600-602.
4. Melekos MD, Chionis HS, Paranychianakis GS, Dauaher HH: Intravesical 4′-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin: A controlled prospective study on the prophylaxis of superficial bladder cancer. Cancer 1993;72:1749-1755.
5. Okamura K, Murase T, Obata K, Ohshima S, Ono Y, Sakata T, Hasegawa Y, Shimoji T, Miyake K: A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. Cancer Chemother Pharmacol 1994;35 (suppl):31-35.
6. Morales A, Eidinger D, Bruce AW: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976;116: 180-183.
7. Brosman SA: BCG in the management of superficial bladder cancer. Urology 1984;23 (suppl):82-87.
8. deKernion JB, Huang M, Lindner A, Smith RB, Kaufman JJ: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J Urol 1985;133:598-601.
9. Herr HW, Laudone VP, Badalament RA, Octtgen HF, Sogani PC, Freedman BD, Melamed MR, Whitmore WF Jr: Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J Clin Oncol 1988; 6:1450-1455.
10. de Voogt HJ, Rathert P, Beyer-Boon ME: Praxis der Urinzytologie. Berlin, Springer, 1979.
11. Rasmussen K, Peterson BL, Jacobo E, Penick GD, Sall J: Cytologic effects of thiotepa and Adriamycin on normal canine urothelium. Acta Cytol 1980;24:237-243.
12. Murphy WM, Soloway MS, Finebaum PJ: Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 1981;126:461-464.
13. Pust R, Ebner H, Kraushaar J, Rothauge CF: Diagnostische Bewertung von Zellatypien nach Gabe von Mitomycin C (Mitomycin medac®) und Adriamycin (Adriblastin®). Therapiewoche 1982;32:507-514.
14. Koshikawa T, Leyh H, Schenck U: Dignostische Probleme der Urinzytologie nach lokaler Instillationstherapie mit Mitomycin beim oberflächlichen Harnblasenkarzinom. Aktuelle Urol 1991;22:209-212.
15. Mack D, Frick J: Diagnostic problems of urine cytology on initial follow-up after intravesical immunotherapy with Calmette-Guérin bacillus for superficial bladder cancer. Urol Int 1994; 52:204-207.
16. Koss LG: Diagnostic Cytology of the Urinary Tract with Histopathologic and Clinical Correlations. Philadelphia, Lippincott-Raven, 1996.
17. Takashi M, Wakai K, Ohno Y, Murase T, Miyake K: Evaluation of a low-dose intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer. Int Urol Nephrol 1995;27:723-733.
18. Papanicolaou GN, Marshall VF: Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945;101: 519-520.
19. Takashi M, Schenck U, Leyh H, Treiber U: Use of diagnostic categories in urinary cytology. Acta Cytol 1998;42 (suppl):577.
20. Hermanek P, Sobin LH: UICC-International Union against Cancer TNM Classification of Malignant Tumours. ed 4. Heidelberg, Springer, 1987.
21. Koss LG: Tumors of the Urinary Bladder. Atlas of Tumor Pathology, 2nd ser, fase 11. Washington, Armed Forces Institute of Pathology, 1975.
22. Schwalb MD, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR: Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guérin therapy: Pattern of recurrence. J Urol 1994;152:382-387.
23. Takashi M, Shimoji T, Murase T, Sakata T, Sobajima T, Suzuki Y: Intravesical bacillus Calmette-Guérin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder. Int Urol Nephrol 1997;29:557-563.
24. Badalament RA, Gay H, Cibas ES, Herr HW, Whitmore WF Jr, Fair WR, Melamed MR: Monitoring intravesical bacillus Calmette-Guérin treatment of superficial bladder carcinoma by postoperative urinary cytology. J Urol 1987;138:763-765.
25. Piscioli F, Pusiol T, Polla E, Failoni G, Luciani L: Urinary cytology of tuberculosis of the bladder. Acta Cytol 1985;29:125-131.
26. Koss LG: The Urinary Tract in the Absence of Cancer: Diagnostic Cytology and Its Histopathologic Bases. Philadelphia, Lippincott, 1992, pp 890-993.
27. Herr HW: Use of bacillus Calmette-Guérin vaccine: Indications and results; in Soloway MS, Paulson DF (eds): Problems in Urology: Transitional Cell Malignancy. Philadelphia, Lippincott, 1992, vol 6, pp 484-492.
28. Pagano F, Bassi P, Milani C, Meneghini A, Maruzzi D, Garbeglio A: A low dose bacillus Calmette-Guérin regimen in superficial bladder cancer therapy: Is it effective? J Urol 1991; 146:32-35.
29. Akaza H, Hinotsu S, Aso Y, Kakizoe T, Koiso K: Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder: Four-year results. Cancer 1995;75:552-559.
30. Wiener HG, Vooijs GP, van't Hof-Grootenboer B: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993;37:163-169.